In the US alone, 1.1 million individuals are living with the progressive neurodegenerative movement disorder, and 90,000 are diagnosed each year.
News|Articles|April 22, 2022
Investigators of Rutgers IFH Report Teen Overdoses Related to Drugs for Common Mental Health Issues
Researchers of the Rutgers Institute for Health, Health Care Policy, and Aging Research noted that physicians need to weigh the risks and benefits of drugs used to treat common mental health conditions amid reported overdoses.
A study published in Pediatrics, led by researchers of the Rutgers Institute for Health, Health Care Policy, and Aging Research (IFH), showed that a high number of teens and young adults with an overdose involving a benzodiazepine (BZD) or psychostimulant—medications commonly used to treat mental health issues—have a recent medical prescription for a BZD or stimulant.
Findings indicated that 29% of youth with overdoses involving BZD had a doctor-written prescription dispensed in the prior month and 42% in the prior 6 months, whereas 25% of youth with an overdose involving stimulants had a stimulant prescription dispensed in the prior month and 39% in the prior 6 months.
“Given that a substantial proportion of youth with overdoses involving BZD or stimulants have prescriptions for these drugs in the prior months, physician encounters when these medications are prescribed may offer an opportunity to identify youth at high risk of overdose,” said corresponding author Greta Bushnell, a core member of the Center for Pharmacoepidemiology and Treatment Sciences at Rutgers IFH.
Related to this article
Baricitinib is now FDA approved for adolescents 12 and older with severe alopecia areata, extending the once-daily pill beyond adults.
A new type of eye drug matched standard anti-VEGF therapy in a large trial for diabetic macular edema, a disease affecting 1.6 million Americans.
At a Stakeholder Interchange convened by The American Journal of Managed Care® in Tampa, Florida, an academic-community mix of hematologist-oncologists and pharmacists debated prior authorization, site-of-care payment disparities, and how aggressively to push bispecific antibody regimens to community practices treating patients with relapsed/refractory multiple myeloma.
Portuguese patch testing finds many chronic hand eczema cases link to allergic contact dermatitis—especially occupational exposures like methylisothiazolinone, HEMA acrylates, thiuram mix, nickel.
The National Comprehensive Cancer Network update on mantle cell lymphoma puts covalent BTK inhibitors, MRD testing, and TP53 sequencing at the center of frontline care, while adding pirtobrutinib and a pair of CAR T-cell therapies for disease that progresses on a BTK inhibitor.
CDC's David A. Siegel, MD, MPH, on rising cancer diagnoses, falling deaths, and where CDC's cancer control resources go next.
These findings demonstrate substantial but variable use of community care consultations for specialty care among patients with diabetic foot ulcers within the Veterans Health Administration.
Trending on AJMC
1
NCCN Journal Publishes Guidelines Update in Mantle Cell Lymphoma
2
Peptide Regulation Debate Intensifies After FDA Advisory Panel's Controversial Vote
3
Health System Pharmacies Keep Patients on GLP-1 Therapy
4
Switching to Subcutaneous Ocrelizumab for MS Could Free 883 Chair Hours in a Year
5